Lisa Togashi, MD
Family Medicine · Aiea, HINPI 1326161175
Payments from drug & device makers
Across 54 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$359
- Amarin Pharma, Inc.$164
- Lilly USA, LLC$117
- Astellas Pharma US Inc$93
- Novartis$92
- Amgen$89
- plus $181 from 9 others
What the payments were for
- Food & beverage$1,096100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $359 |
| Amarin Pharma, Inc. | 7 | $164 |
| Lilly USA, LLC | 5 | $117 |
| Astellas Pharma US Inc | 5 | $93 |
| Novartis | 4 | $92 |
| Amgen | 4 | $89 |
| AstraZeneca | 2 | $38 |
| Johnson & Johnson | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Radius Health, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Boston Scientific | 1 | $17 |
| Smith+Nephew | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$1,096 in reported general payments places this provider in the 75th percentile of 376 family medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colesevelam Hcl | 26 | $16,166 |
| Fluticasone Propionate | 26 | $4,740 |
| Atorvastatin Calcium | 142 | $4,268 |
| Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide | 23 | $1,784 |
| Metformin Hcl ErMetformin Hcl | 56 | $1,378 |
| Amlodipine Besylate | 65 | $1,346 |
| Valsartan | 34 | $1,240 |
| Losartan Potassium | 38 | $1,085 |
| Lovastatin | 22 | $1,063 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $1,062 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 16 | $983 |
| SynthroidLevothyroxine Sodium | 14 | $788 |
| Metoprolol Succinate | 24 | $768 |
| Pravastatin Sodium | 24 | $639 |
| Irbesartan | 16 | $573 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Aiea
- Dean OtakaAiea$10K
- Randall NittaAiea$4K
- Hugh MooreKoloa$237K
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
- Johnnie YatesHonolulu$25K
- Edward AlqueroWaipahu$24K
- Noelani HobbsWaipahu$23K
- Rainier Dennis BautistaLihue$23K
- Choon YeoHonolulu$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.